Valentina Agudelo identified a critical gap in breast cancer survival rates in Latin America, prompting the creation of Salva Health, which focuses on innovative early detection.
Agudelo stated, 'I just couldn't let go of the problem we had identified,' emphasizing her commitment to addressing late detection of breast cancer in Latin America.
Salva Health's product, Julietta, is designed for quick tissue density measurements through electrodes, linking results to digital devices, ensuring faster screening for women.
Although Julieta is not a substitute for mammograms, it's crucial for identifying abnormalities. Agudelo noted, 'With that information, insurance companies can prioritize women for proper diagnosis.'
Collection
[
|
...
]